SlideShare a Scribd company logo
1 of 6
Guías prevención CV Alberto Esteban Fernández
2019 ACC/ AHA GUIDELINE
ON THE PRIMARY PREVENTION
OF CARDIOVASCULAR DISEASE
Guías prevención CV Alberto Esteban Fernández
Guías prevención CV Alberto Esteban Fernández
Top 10 Take – Home Messages
for the Primary Prevention
of Cardiovascular Disease
Guías prevención CV Alberto Esteban Fernández
1. The most important way to prevent atherosclerotic vascular disease, heart failure, and
atrial fibrillation is to promote a healthy lifestyle throughout life.
2. A team-based care approach is an effective strategy for the prevention of
cardiovascular disease. Clinicians should evaluate the social determinants of health
that affect individuals to inform treatment decisions.
3. Adults who are 40 to 75 years of age and are being evaluated for cardiovascular
disease prevention should undergo 10-year atherosclerotic cardiovascular disease
(ASCVD) risk estimation and have a clinician–patient risk discussion before starting on
pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. In
addition, assessing for other risk-enhancing factors can help guide decisions about
preventive interventions in select individuals, as can coronary artery calcium scanning.
Guías prevención CV Alberto Esteban Fernández
4. All adults should consume a healthy diet that emphasizes the intake of vegetables,
fruits, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the
intake of trans fats, processed meats, refined carbohydrates, and sweetened
beverages. For adults with overweight and obesity, counseling and caloric restriction
are recommended for achieving and maintaining weight loss.
5. Adults should engage in at least 150 minutes per week of accumulated moderate-
intensity physical activity or 75 minutes per week of vigorous-intensity physical activity.
6. For adults with type 2 diabetes mellitus, lifestyle changes, such as improving dietary
habits and achieving exercise recommendations, are crucial. If medication is indicated,
metformin is first-line therapy, followed by consideration of a sodium-glucose
cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist.
Guías prevención CV Alberto Esteban Fernández
7. All adults should be assessed at every healthcare visit for tobacco use, and those who
use tobacco should be assisted and strongly advised to quit.
8. Aspirin should be used infrequently in the routine primary prevention of ASCVD
because of lack of net benefit.
9. Statin therapy is first-line treatment for primary prevention of ASCVD in patients with
elevated lowdensity lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes
mellitus, who are 40 to 75 years of age, and those determined to be at sufficient
ASCVD risk after a clinician–patient risk discussion.
10. Nonpharmacological interventions are recommended for all adults with elevated blood
pressure or hypertension. For those requiring pharmacological therapy, the target
blood pressure should generally be <130/80 mm Hg.

More Related Content

What's hot

Resistant hypertension
Resistant hypertensionResistant hypertension
Resistant hypertensionBasem Enany
 
Hypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptxHypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptxdesktoppc
 
New oral anticoagulants (NOAC) WATAG guidelines
New oral anticoagulants (NOAC) WATAG guidelinesNew oral anticoagulants (NOAC) WATAG guidelines
New oral anticoagulants (NOAC) WATAG guidelinesSCGH ED CME
 
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?drucsamal
 
Targeting lipids: a primary and secondary care perspective
Targeting lipids: a primary and secondary care perspectiveTargeting lipids: a primary and secondary care perspective
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fractionMedPeds Hospitalist
 
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMDIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMPraveen Nagula
 
Role of Statin in Secondary Prevention of ACS
Role of Statin in Secondary Prevention of ACSRole of Statin in Secondary Prevention of ACS
Role of Statin in Secondary Prevention of ACSPERKI Pekanbaru
 
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...vaibhavyawalkar
 
2019 cardio vascular disease prevention-guidelines
2019 cardio vascular disease  prevention-guidelines 2019 cardio vascular disease  prevention-guidelines
2019 cardio vascular disease prevention-guidelines DIPAK PATADE
 
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...vaibhavyawalkar
 
Anticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillationAnticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillationMashiul Alam
 
Optimizing heart failure management
Optimizing heart failure managementOptimizing heart failure management
Optimizing heart failure managementikramdr01
 
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough
Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough Dr Vivek Baliga
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsahvc0858
 
What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“Arindam Pande
 

What's hot (20)

Resistant hypertension
Resistant hypertensionResistant hypertension
Resistant hypertension
 
PARADIGM HF TRIAL
PARADIGM HF TRIALPARADIGM HF TRIAL
PARADIGM HF TRIAL
 
EMPEROR - Reduced Trial
EMPEROR - Reduced TrialEMPEROR - Reduced Trial
EMPEROR - Reduced Trial
 
Hypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptxHypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptx
 
New oral anticoagulants (NOAC) WATAG guidelines
New oral anticoagulants (NOAC) WATAG guidelinesNew oral anticoagulants (NOAC) WATAG guidelines
New oral anticoagulants (NOAC) WATAG guidelines
 
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
 
Targeting lipids: a primary and secondary care perspective
Targeting lipids: a primary and secondary care perspectiveTargeting lipids: a primary and secondary care perspective
Targeting lipids: a primary and secondary care perspective
 
Hypertension Guide Lines for 2020
Hypertension Guide Lines for 2020Hypertension Guide Lines for 2020
Hypertension Guide Lines for 2020
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMDIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
 
Role of Statin in Secondary Prevention of ACS
Role of Statin in Secondary Prevention of ACSRole of Statin in Secondary Prevention of ACS
Role of Statin in Secondary Prevention of ACS
 
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
 
2019 cardio vascular disease prevention-guidelines
2019 cardio vascular disease  prevention-guidelines 2019 cardio vascular disease  prevention-guidelines
2019 cardio vascular disease prevention-guidelines
 
Antiplatelet Therapy: What’s New, Older Agents and How They Work
Antiplatelet Therapy: What’s New, Older Agents and How They WorkAntiplatelet Therapy: What’s New, Older Agents and How They Work
Antiplatelet Therapy: What’s New, Older Agents and How They Work
 
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
 
Anticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillationAnticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillation
 
Optimizing heart failure management
Optimizing heart failure managementOptimizing heart failure management
Optimizing heart failure management
 
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough
Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
 
What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“
 

Similar to 2019 ACC/AHA Primary Prevention Guidelines

2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-preventionPHAM HUU THAI
 
2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.pptHimaniPandya16
 
Lec 6 preventive cardiology for mohs
Lec 6  preventive cardiology for mohsLec 6  preventive cardiology for mohs
Lec 6 preventive cardiology for mohsEhealthMoHS
 
C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015Diabetes for all
 
C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15Diabetes for all
 
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga
 
C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15Diabetes for all
 
ESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptxESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptxAshfakAlArifShuvon
 
preventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disorderspreventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disordersBaqer Aliraqi
 
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ingSalon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ingtyfngnc
 
Management of diabetes in elderly
Management of diabetes in elderlyManagement of diabetes in elderly
Management of diabetes in elderlyAditya Sarin
 
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...Dr Ranjit Jagtap
 
Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...Aditi Jagtap Pune
 
Highlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes managementHighlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes managementAhmed Elmoughazy
 
SOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from studentsSOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from studentsYajjatGarg
 
CORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptxCORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptxRamya569989
 

Similar to 2019 ACC/AHA Primary Prevention Guidelines (20)

2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention
 
2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt
 
Diabetes and elderly
Diabetes and elderlyDiabetes and elderly
Diabetes and elderly
 
Lec 6 preventive cardiology for mohs
Lec 6  preventive cardiology for mohsLec 6  preventive cardiology for mohs
Lec 6 preventive cardiology for mohs
 
ADA '23 old pt-f&f.pptx
ADA '23 old pt-f&f.pptxADA '23 old pt-f&f.pptx
ADA '23 old pt-f&f.pptx
 
C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015
 
C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15
 
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
 
C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15
 
ESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptxESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptx
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
preventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disorderspreventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disorders
 
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ingSalon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
 
Management of diabetes in elderly
Management of diabetes in elderlyManagement of diabetes in elderly
Management of diabetes in elderly
 
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
 
Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...
 
Highlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes managementHighlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes management
 
BSN Capstone Project Examples
BSN Capstone Project ExamplesBSN Capstone Project Examples
BSN Capstone Project Examples
 
SOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from studentsSOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from students
 
CORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptxCORONARY ARTERY DISEASE.pptx
CORONARY ARTERY DISEASE.pptx
 

More from Sociedad Española de Cardiología

Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...Sociedad Española de Cardiología
 
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisiránePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisiránSociedad Española de Cardiología
 

More from Sociedad Española de Cardiología (20)

Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
 
Estudio IVUS-ACS
Estudio IVUS-ACSEstudio IVUS-ACS
Estudio IVUS-ACS
 
Estudio PREVENT
Estudio PREVENTEstudio PREVENT
Estudio PREVENT
 
Estudio DEDICATE-DZHK6
Estudio DEDICATE-DZHK6Estudio DEDICATE-DZHK6
Estudio DEDICATE-DZHK6
 
Estudio TRAVERSE
Estudio TRAVERSEEstudio TRAVERSE
Estudio TRAVERSE
 
Estudio FULL-REVASC
Estudio FULL-REVASCEstudio FULL-REVASC
Estudio FULL-REVASC
 
Estudio IMPROVE-HCM
Estudio IMPROVE-HCMEstudio IMPROVE-HCM
Estudio IMPROVE-HCM
 
Estudio ORBITA-COSMIC
Estudio ORBITA-COSMICEstudio ORBITA-COSMIC
Estudio ORBITA-COSMIC
 
Estudio ARISE-HF
Estudio ARISE-HFEstudio ARISE-HF
Estudio ARISE-HF
 
Estudio TACTiC
Estudio TACTiCEstudio TACTiC
Estudio TACTiC
 
Estudio ULTIMATE DAPT
Estudio ULTIMATE DAPTEstudio ULTIMATE DAPT
Estudio ULTIMATE DAPT
 
Estudio SHASTA-2
Estudio SHASTA-2Estudio SHASTA-2
Estudio SHASTA-2
 
Estudio MINT
Estudio MINTEstudio MINT
Estudio MINT
 
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisiránePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
 
Estudio SMART
Estudio SMARTEstudio SMART
Estudio SMART
 
Estudio REDUCE-AMI
Estudio REDUCE-AMIEstudio REDUCE-AMI
Estudio REDUCE-AMI
 
Estudio DANGER
Estudio DANGEREstudio DANGER
Estudio DANGER
 
Estudio Liberate-HR
Estudio Liberate-HREstudio Liberate-HR
Estudio Liberate-HR
 
Estudio TELE-ACS
Estudio TELE-ACSEstudio TELE-ACS
Estudio TELE-ACS
 
BRIDGE-TIMI-73a
BRIDGE-TIMI-73aBRIDGE-TIMI-73a
BRIDGE-TIMI-73a
 

Recently uploaded

Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxUmerFayaz5
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptxkhadijarafiq2012
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PPRINCE C P
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSérgio Sacani
 

Recently uploaded (20)

Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptx
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptx
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C P
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 

2019 ACC/AHA Primary Prevention Guidelines

  • 1. Guías prevención CV Alberto Esteban Fernández 2019 ACC/ AHA GUIDELINE ON THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
  • 2. Guías prevención CV Alberto Esteban Fernández
  • 3. Guías prevención CV Alberto Esteban Fernández Top 10 Take – Home Messages for the Primary Prevention of Cardiovascular Disease
  • 4. Guías prevención CV Alberto Esteban Fernández 1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2. A team-based care approach is an effective strategy for the prevention of cardiovascular disease. Clinicians should evaluate the social determinants of health that affect individuals to inform treatment decisions. 3. Adults who are 40 to 75 years of age and are being evaluated for cardiovascular disease prevention should undergo 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation and have a clinician–patient risk discussion before starting on pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. In addition, assessing for other risk-enhancing factors can help guide decisions about preventive interventions in select individuals, as can coronary artery calcium scanning.
  • 5. Guías prevención CV Alberto Esteban Fernández 4. All adults should consume a healthy diet that emphasizes the intake of vegetables, fruits, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the intake of trans fats, processed meats, refined carbohydrates, and sweetened beverages. For adults with overweight and obesity, counseling and caloric restriction are recommended for achieving and maintaining weight loss. 5. Adults should engage in at least 150 minutes per week of accumulated moderate- intensity physical activity or 75 minutes per week of vigorous-intensity physical activity. 6. For adults with type 2 diabetes mellitus, lifestyle changes, such as improving dietary habits and achieving exercise recommendations, are crucial. If medication is indicated, metformin is first-line therapy, followed by consideration of a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist.
  • 6. Guías prevención CV Alberto Esteban Fernández 7. All adults should be assessed at every healthcare visit for tobacco use, and those who use tobacco should be assisted and strongly advised to quit. 8. Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit. 9. Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated lowdensity lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion. 10. Nonpharmacological interventions are recommended for all adults with elevated blood pressure or hypertension. For those requiring pharmacological therapy, the target blood pressure should generally be <130/80 mm Hg.